z-logo
open-access-imgOpen Access
Dermatitis bullosa como efecto secundario a pembrolizumab
Author(s) -
Al�cia da Silva Oliveira,
Em�lio Macias Bravo
Publication year - 2022
Publication title -
galicia clínica
Language(s) - Spanish
Resource type - Journals
eISSN - 1989-3922
pISSN - 0304-4866
DOI - 10.22546/64/2467
Subject(s) - pembrolizumab , dermatology , medicine , cancer , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here